Sign In
Buy MRNS
$0.550
+0 (+0%)
At Close: May 09, 2025
Ladenburg Thalmann & Co. Maintains a Buy Rating on Marinus (MRNS) - Markets
10:38am, Wednesday, 01'st Jul 2020
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on Marinus (MRNS –
Oppenheimer Reaffirms Their Buy Rating on Marinus (MRNS) - Markets
01:54am, Wednesday, 01'st Jul 2020
Oppenheimer analyst Jay Olson maintained a Buy rating on Marinus (MRNS – Research Report) yesterday and set a price target
Marinus Pharmaceuticals Provides Pipeline Update
11:00am, Tuesday, 30'th Jun 2020
Marinus Pharmaceuticals, Inc. (MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided a pipeline update in advance of i
Two Sigma Investments LP Raises Stake in Marinus Pharmaceuticals Inc (NASDAQ:MRNS)
07:16am, Friday, 26'th Jun 2020
Two Sigma Investments LP raised its position in shares of Marinus Pharmaceuticals Inc (NASDAQ:MRNS) by 78.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exc
Marinus Pharmaceuticals to Host Pipeline Update Webinar
12:00pm, Wednesday, 24'th Jun 2020
RADNOR, Pa., June 24, 2020 -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare.
Marinus Pharmaceuticals to Present at SVB Leerink’s CybeRx Series: 2nd Annual CNS Forum
02:16pm, Monday, 22'nd Jun 2020
RADNOR, Pa., June 22, 2020 -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare.
Marinus Pharmaceuticals Inc (NASDAQ:MRNS) Shares Purchased by Bank of New York Mellon Corp
04:27am, Monday, 22'nd Jun 2020
Bank of New York Mellon Corp raised its stake in shares of Marinus Pharmaceuticals Inc (NASDAQ:MRNS) by 82.5% in the first quarter, according to the company in its most recent disclosure with the Secu
Is the Options Market Predicting a Spike in Marinus (MRNS) Stock?
12:44pm, Wednesday, 17'th Jun 2020
Investors need to pay close attention to Marinus (MRNS) stock based on the movements in the options market lately.
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10:39pm, Tuesday, 16'th Jun 2020
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (the “Company” or “Marinus”), a pharmaceutical company dedicated to the development of innovative therapeutics to
The Devon people who forget their wedding day and narrowly avoid death
12:25pm, Tuesday, 16'th Jun 2020
From narrowly avoiding death, to forgetting their own wedding day, three people share their experiences of living with the condition
Marinus Pharmaceuticals Appoints Martha Manning as Vice President, General Counsel and Secretary
11:30am, Monday, 15'th Jun 2020
Marinus Pharmaceuticals, Inc. (MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat orphan seizure disorders, today announced that Martha Manning, Esq., ha
Marinus Pharmaceuticals Appoints Martha Manning as Vice President, General Counsel and Secretary
12:00am, Monday, 15'th Jun 2020
RADNOR, Pa., June 15, 2020 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of...
The offering raised gross proceeds of approximately $46 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. SunTrust Robinson Humphrey
